The European partnership launched in October 2023 continues its path, aiming to improve outcomes within sustainable healthcare systems through research, development, innovation, and implementation of personalized medicine approaches for the benefit of patients, citizens, and society.
To achieve this, EP PerMed operates through periodic calls to fund research projects carried out by multidisciplinary teams composed of members from multiple countries, the second of which was published yesterday, December 16.
What is the EP PerMed Partnership on Personalized Medicine?
The European Partnership for Personalized Medicine (EP PerMed) is one of the 49 partnerships under Horizon Europe to address some of the major challenges facing our society in the coming decades, funding high-level research that can help tackle these challenges and improve the well-being of the European Union and its citizens and businesses.
